Direct Cost of Parkinson's Disease: A Real-World Data Study of Second-Line Therapies.

MLA

Gomez-Inhiesto, Elisa, et al. “Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies.” Parkinson’s Disease, vol. 2020, May 2020, p. 9106026. EBSCOhost, https://doi.org/10.1155/2020/9106026.

APA

Gomez-Inhiesto, E., Acaiturri-Ayesta, M. T., Ustarroz-Aguirre, I., Camahuali, D., Urtaran-Laresgoiti, M., Basabe-Aldecoa, M., Nuño-Solinís, R., & Urizar, E. (2020). Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies. Parkinson’s Disease, 2020, 9106026. https://doi.org/10.1155/2020/9106026

Chicago

Gomez-Inhiesto, Elisa, María Teresa Acaiturri-Ayesta, Iker Ustarroz-Aguirre, Diana Camahuali, Maider Urtaran-Laresgoiti, Marisol Basabe-Aldecoa, Roberto Nuño-Solinís, and Elena Urizar. 2020. “Direct Cost of Parkinson’s Disease: A Real-World Data Study of Second-Line Therapies.” Parkinson’s Disease 2020 (May): 9106026. doi:10.1155/2020/9106026.